ASRS
ADMA icon

Arizona State Retirement System’s ADMA Biologics ADMA Stock Holding History

Arizona State Retirement System’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$510K Sell
60,900
-4,472
-7% -$40.8K ﹤0.01% 1524
2026
Q1 		$589K Sell
65,372
-1,036
-2% -$16.3K ﹤0.01% 1379
2025
Q4 		$1.21M Sell
66,408
-4,215
-6% -$71K 0.01% 1003
2025
Q3 		$1.04M Buy
70,623
+1,307
+2% +$22.4K 0.01% 1121
2025
Q2 		$1.26M Buy
69,316
+1,531
+2% +$31.2K 0.01% 986
2025
Q1 		$1.34M Buy
67,785
+204
+0.3% +$3.53K 0.01% 917
2024
Q4 		$1.16M Buy
67,581
+4,170
+7% +$78.5K 0.01% 1026
2024
Q3 		$1.27M Buy
63,411
+1,770
+3% +$27.5K 0.01% 986
2024
Q2 		$689K Buy
61,641
+2,645
+4% +$22.2K ﹤0.01% 1254
2024
Q1 		$389K Sell
58,996
-732
-1% -$4K ﹤0.01% 1577
2023
Q4 		$270K Buy
59,728
+2,769
+5% +$10.2K ﹤0.01% 1788
2023
Q3 		$204K Buy
56,959
+776
+1% +$2.99K ﹤0.01% 1893
2023
Q2 		$207K Sell
56,183
-603
-1% -$2.23K ﹤0.01% 1938
2023
Q1 		$188K Buy
56,786
+9,690
+21% +$33.5K ﹤0.01% 1956
2022
Q4 		$183K Buy
+47,096
New +$145K ﹤0.01% 1950

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Arizona State Retirement System's ADMA Position: Q2 2026 in Review

Arizona State Retirement System reduced its ADMA Biologics (ADMA) stake by 6.8% in Q2 2026, selling an estimated $40.8K and leaving 60,900 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

Arizona State Retirement System first reported a position in ADMA in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.34M in Q1 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Arizona State Retirement System held 60,900 shares of ADMA Biologics worth $510K as of Q2 2026.
  • Arizona State Retirement System sold 4,472 ADMA Biologics shares in Q2 2026, an estimated $40.8K.
  • ADMA Biologics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1524 holding.
  • Arizona State Retirement System first reported a position in ADMA Biologics in Q4 2022 and has held it in 15 quarters since.
  • Arizona State Retirement System's ADMA Biologics position peaked at $1.34M in Q1 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.